Stereotactic prostate adaptive radiotherapy utilising kilovoltage intrafraction monitoring: the TROG 15.01 SPARK trial
Crossref DOI link: https://doi.org/10.1186/s12885-017-3164-1
Published Online: 2017-03-08
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Keall, Paul
Nguyen, Doan Trang
O’Brien, Ricky
Booth, Jeremy
Greer, Peter
Poulsen, Per
Gebski, Val
Kneebone, Andrew
Martin, Jarad
Funding for this research was provided by:
The SPARK trial is co-funded by the Prostate Cancer Foundation of Australia and Cancer Australia